Impinj, Inc. — FY2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021. The filing also reports unaudited fourth-quarter results. Impinj develops RAIN RFID chips, readers, gateways and related software used to identify and track physical items. Its business depends on adoption by end users and sales through channel partners.
Financial performance
| Metric | FY2021 | FY2020 |
|---|---|---|
| Revenue | $190.3 million | $138.9 million |
| Gross profit / margin | $99.0 million / 52.0% | $65.1 million / 46.9% |
| Operating loss | $37.2 million | $47.1 million |
| Net loss | $51.3 million | $51.9 million |
| Adjusted EBITDA (non-GAAP) | $9.1 million | $(11.5) million |
| Operating cash flow | $6.5 million | $(16.9) million |
- Revenue rose 37% year over year. Endpoint IC revenue increased to $139.3 million from $102.3 million; systems revenue rose to $51.0 million from $36.6 million.
- Gross margin improved 5.1 percentage points, reflecting product mix and sales of inventory previously reserved, partly offset by ongoing cost and supply pressures.
- Fourth-quarter revenue was $52.6 million, up from $36.4 million in Q4 2020; gross margin was 55.5%. The quarter had a $20.0 million net loss, including $11.3 million of induced-conversion expense tied to the 2019 Notes repurchase.
- Research and development expense increased to $64.1 million; stock-based compensation totaled $40.5 million, up from $25.7 million. FY2021 non-GAAP results exclude specified items, including stock compensation and induced-conversion expense.
- Cash, cash equivalents and short-term investments totaled $193.3 million at year-end; long-term investments were an additional $14.2 million. Working capital was $220.3 million. Management said existing cash and investments should fund anticipated needs for at least 12 months.
- Debt principal outstanding was $297.4 million: $287.5 million of 1.125% convertible notes due 2027 and $9.85 million of 2.0% convertible notes due 2026. The company issued the 2021 Notes and used about $183.6 million of proceeds to repurchase $76.4 million principal of the 2019 Notes.
Material changes and outlook
- FY2021 revenue rebounded from pandemic-affected FY2020, but the company said demand exceeded its ability to supply products. Endpoint IC wafer supply was tight, and component shortages and higher costs constrained systems production.
- Management reported wafer supply commitments at roughly Q4 2021 levels through at least mid-2022, but supply thereafter was less certain. It warned that constrained supply could limit shipments and market share; customer buying ahead of shortages could also lead to later demand declines.
- Impinj raised prices beginning in October 2021 to offset higher input costs. Management expected near-term margins to remain volatile due to product mix, supply costs and timing of price changes. The filing provides no specific numerical revenue or earnings guidance.
- COVID-19 continued to delay pilots, deployments, travel and manufacturing activity. Management cited uncertain effects on retail, aviation and other end markets, while noting potential demand opportunities in supply chain and logistics.
- Key business risks include uncertain RAIN adoption, competition and price pressure, reliance on a limited number of customers and channel partners, and reliance on third-party suppliers without long-term wafer-supply contracts. Avery Dennison represented 32% of FY2021 revenue and Arizon 11%; 83% of revenue was from outside the United States.
- Other notable items: the company incurred $1.7 million of restructuring costs after eliminating about seven positions. NXP patent litigation remained active in multiple jurisdictions; outcomes were uncertain. The shareholder derivative settlement was approved in November 2021. The financial-statement audit and internal-control audit opinions were unqualified, and management and the auditor reported effective internal controls at year-end.
Investor verification points
- Check subsequent disclosures on wafer allocation, production capacity, component costs, shipments and whether supply constraints persist beyond mid-2022.
- Assess customer concentration, channel inventory and end-user demand, particularly in retail and among Avery Dennison and Arizon.
- Review the convertible-note terms, potential conversion dilution or cash settlement obligations, and the use of proceeds from the 2021 issuance.
- Reconcile GAAP losses with non-GAAP measures, including the effects of $40.5 million in stock-based compensation and the $11.3 million induced-conversion charge.
- Monitor NXP litigation developments and any material changes in legal contingencies or related costs.